S1703

Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored with Serum Tumor Marker Directed Disease Monitoring (STMDDM) versus Usual Care in Patients with Metastatic Hormone Receptor Positive Breast Cancer
Contact phone
Janet Davids, RN 517-364-2811
Principal investigator
Gordan Srkalovic
Trial Category
Cancer
Trial SubCategory
Breast